12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Thursday's intraday session, several healthcare stocks experienced significant movements. Acer Therapeutics (ACER), Aditxt (ADTX), NeuBase Therapeutics (NBSE), Longeveron Inc. - Subscription Right (LGVNR), OpGen (OPGN), and Cue Health (HLTH) saw their shares rise, with ACER leading the gainers with a 141.8% increase. On the other hand, Axcella Health (AXLA), OKYO Pharma (OKYO), Aravive (ARAV), Ontrak (OTRK), AEON Biopharma (AEON), and Ontrak (OTRKP) experienced a decline in their stock prices, with AXLA leading the losers with a 30% decrease.
August 31, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acer Therapeutics shares rose by 141.8% during Thursday's session, trading at a volume of 117.5 million, which is significantly higher than its average full-day volume over the last 100 days.
The significant increase in Acer Therapeutics' share price and trading volume suggests a positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Aditxt shares rose by 112.14% during Thursday's session, trading at a volume of 563.6K, which is significantly higher than its average full-day volume over the last 100 days.
The significant increase in Aditxt's share price and trading volume suggests a positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Axcella Health shares fell by 30% during Thursday's session, trading at a volume of 13.8 million, which is higher than its average full-day volume over the last 100 days.
The significant decrease in Axcella Health's share price and the increase in trading volume suggests a negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
OKYO Pharma shares decreased by 22.6% during Thursday's session, trading at a volume of 317.8K, which is higher than its average full-day volume over the last 100 days.
The significant decrease in OKYO Pharma's share price and the increase in trading volume suggests a negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100